ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1942

$456K Total Retail Price of All Prescriptions

Rank: 144 out of 1942

557 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 611 554 1 1
LISINOPRIL 447 381 2 2
LEVOTHYROXINE SODIUM 443 393 3 3
FUROSEMIDE 426 403 4 5
OMEPRAZOLE 379 335 5 4
HYDROCODONE-ACETAMINOPHEN 329 274 S3 6 12
CITALOPRAM HBR 325 247 7 15
POTASSIUM CHLORIDE 308 272 8 17
METOPROLOL SUCCINATE 294 273 9 13
METOPROLOL TARTRATE 290 267 10 9
HYDROCHLOROTHIAZIDE 279 244 11 8
WARFARIN SODIUM 275 264 12 11
AMLODIPINE BESYLATE 256 242 13 6
GABAPENTIN 247 212 14 16
TRAMADOL HCL 216 176 15 19
METFORMIN HCL 192 170 16 10
ATENOLOL 167 154 17 7
DIGOXIN 153 149 18 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 147 19 22
LOSARTAN POTASSIUM 128 104 20 18
CARVEDILOL 124 117 21 39
SERTRALINE HCL 121 91 22 20
DONEPEZIL HCL 114 114 23 30
GLYBURIDE 113 101 R 24 69
TAMSULOSIN HCL 105 83 25 29
ISOSORBIDE MONONITRATE ER 104 104 26 42
ATORVASTATIN CALCIUM 95 83 27 14
TRIAMTERENE-HCTZ 94 89 28 36
CLOPIDOGREL 89 80 29 55
FENTANYL 87 73 S2 30 47
MIRTAZAPINE 87 87 30 38
CARBIDOPA-LEVODOPA 86 86 32 64
ALLOPURINOL 85 82 33 26
RISPERIDONE 77 53 34 68
CIPROFLOXACIN HCL 76 68 35 79
METOLAZONE 76 64 35 145
POLYETHYLENE GLYCOL 3350 76 67 35 28
LANTUS 72 42 38 49
QUETIAPINE FUMARATE 72 56 38 61
NAMENDA 67 67 40 51
LANTUS SOLOSTAR 67 65 40 54
PROPRANOLOL HCL 67 66 40 101
RANITIDINE HCL 61 43 43 31
PROAIR HFA 60 57 44 41
PRAMIPEXOLE DIHYDROCHLORIDE 55 55 45 110
ZOLPIDEM TARTRATE 52 49 46 25
TERAZOSIN HCL 51 51 47 77
IBUPROFEN 50 42 48 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.